(Press-News.org) FINDINGS: By determining how corticosteroids act to increase production of red blood cell progenitors, Whitehead Institute researchers have identified a class of drugs that may be beneficial in treating some erythropoietin-resistant anemias. One such anemia is Diamond-Blackfan anemia (DBA), which is frequently treated with corticosteroids, despite their severe side-effects. The identified class of drugs may be able to treat other anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.
RELEVANCE: Some common anemias can be treated with the hormone erythropoietin (EPO), which stimulates red blood-cell production. However, certain anemias, including DBA, do not respond to EPO, creating a large unmet medical need.
CAMBRIDGE, Mass. (December 22, 2010) – By determining how corticosteroids act to promote red blood cell progenitor formation, Whitehead Institute researchers have identified a class of drugs that may be beneficial in anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.
Anemia occurs due to a breakdown in erythropoiesis, the multi-step process that creates red blood cells. Some common anemias can be treated with a recombinant form of the hormone erythropoietin (EPO), which normally stimulates red blood-cell production at a fairly early stage of erythropoiesis.
However, certain anemias fail to respond to EPO, creating a large unmet medical need. In the case of Diamond Blackfan anemia (DBA), patients lack a sufficient number of EPO-responsive cells. Instead, corticosteroids such as prednisone or prednisolone are used to treat DBA, although it has been unclear exactly how these agents affect erythropoiesis.
To see how corticosteroids are able to increase red blood cell counts, Johan Flygare, a postdoctoral researcher in the lab of Whitehead Institute Founding Member Harvey Lodish, purified two progenitors of red blood cells, called burst forming unit-erythroids (BFU-Es) and colony forming unit-erythroids (CFU-Es), from mouse fetal liver cells. During erythropoiesis, BFU-Es produce CFU-Es, which are then stimulated by EPO to generate the pro-erythroblasts that eventually become red blood cells. By dividing numerous times before maturing, both BFU-Es and CFU-Es have a limited ability to self-renew. When Flygare exposed BFU-Es and CFU-Es in vitro to a corticosteroid, only the BFU-Es responded--dividing 13 times instead of the usual 9 times before maturing into CFU-Es. These additional cell divisions ultimately led to a 13-fold increase in red blood-cell production.
Flygare identified 83 genes in BFU-Es that are stimulated by the corticosteroid, and he examined the promoters that facilitate those genes' transcription. The promoters appeared to have binding sites for a transcription factor, called hypoxia-induced factor 1-alpha (HIF1-alpha), that is activated when an organism is deprived of oxygen. To prolong the 83 genes' promotion by HIF1-alpha, Flygare used a class of drugs known as prolyl hydroxylase inhibitors (PHIs), which extends HIF1-alpha's effectiveness. PHIs have also been used in early-stage clinical trials to increase EPO production.
When Flygare added both a corticosteroid and a PHI to BFU-Es in culture, the cells produced 300 times more red blood cells than did cells without exposure to the drugs. Flygare repeated the experiment with adult human BFU-Es, and found that a corticosteroid plus a PHI generated 10 times more red blood cells than BFU-Es exposed to a corticosteroid alone.
Flygare hopes this research eventually leads to improved treatment for DBA patients who currently suffer from a host of corticosteroid-induced side effects, including decreased bone density, immunosuppression, stunted growth, and cataracts.
"If you could lower the dose of steroids so DBA patients would get just a little bit, and then add on this kind of drug, like a PHI, that would boost the effect, maybe you could get around the steroids' side effects," says Flygare. "That would be good."
This new approach to increasing erythropoiesis by extending the self-renewal of BFU-Es—resulting in creation of more EPO-responsive cells—could lead to novel therapies for other anemias.
"There are a number of anemias that are much more prevalent than DBA and that cannot be treated with EPO, either, such as anemias from trauma, sepsis, malaria, and anemia in kidney dialysis patients," says Lodish, who is also a professor of biology and bioengineering at MIT. "Whether these treatments will work in those conditions remains to be seen."
###
This research was supported by the Diamond Blackfan Anemia Foundation, the Swedish Research Council, Maja och Hjalmar Leanders Stiftelse, The Sweden-America Foundation, and the National Institutes of Health (NIH).
Written by Nicole Giese
Harvey Lodish's primary affiliation is with Whitehead Institute for Biomedical Research, where his laboratory is located and all his research is conducted. He is also a professor of biology and a professor of bioengineering at Massachusetts Institute of Technology.
Full Citations:
"HIF-1 Alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal"
Blood, published online the week of December 22, 2010
Johan Flygare (1), Violeta Rayon Estrada (1), Chanseok Shin (1, 2), Sumeet Gupta (1), and Harvey F. Lodish (1, 3, 4).
1. Whitehead Institute for Biomedical Research, Cambridge, MA 02142
2. Department of Agricultural Biotechnology, Seoul National University, Seoul, 151-921, Republic of Korea
3. Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, MA
END
Researchers at Cleveland Clinic's Genomic Medicine Institute have revealed multiple genetic discoveries that may permit easier diagnosis and disease management for Cowden syndrome patients who are predisposed to breast and kidney cancer.
The research, which could allow for earlier discovery of cancerous tumors, is published in the Dec. 22 issue of the Journal of the American Medical Association (JAMA).
Charis Eng, M.D., Ph.D, Chair of the Genomic Medicine Institute at Cleveland Clinic, led the research. It revealed KILLIN as a novel predisposition gene for Cowden ...
December 21, 2010 — (BRONX, NY) — Two researchers at Albert Einstein College of Medicine of Yeshiva University have found that our 98.6° F (37° C) body temperature strikes a perfect balance: warm enough to ward off fungal infection but not so hot that we need to eat nonstop to maintain our metabolism.
"One of the mysteries about humans and other advanced mammals has been why they are so hot compared with other animals," said study co—author Arturo Casadevall, M.D., Ph.D., professor and chair of microbiology & immunology at Einstein. "This study helps to explain why mammalian ...
Projectors are getting smaller and smaller. Now that pictures are available in digital format almost everywhere, we need projectors to beam giant photos and films onto walls. Projectors contain lenses that spread the light from the pixelated source in such a way as to illuminate the image area evenly. Until now, this was done using complicated arrays of lenses placed one behind the other. Recently, the same effect has been achieved using flat lens arrays made up of thousands of identical microlenses. This kind of array takes up much less space and does not need to be painstakingly ...
The only way to learn if your water source has hexavalent chromium is to check with your public water supplier and request a water quality report, said NJIT Professor Taha Marhaba, a civil/environmental engineer. Most municipal or city engineers should be able to provide such a report upon request. Additional information specifically about hexavalent chromium levels may also be available.
"In general, hexavalent chromium can be found in either surface or groundwater sources and its source can be either natural or man-made industrial operations that have used chromium," ...
About 50 miles from Bethlehem, a drilling project is determining the climate and earthquake activity of the Holy Land. Scientists from eight nations are examining the ground below the Dead Sea, by placing a borehole in this deepest basin in the world. The International Continental Scientific Drilling Program ICDP brings together research teams from Israel, Japan, Norway, Switzerland, the USA and Germany. Particularly noteworthy: Researchers from Jordan and Palestine are also involved.
Scientists and technicians of the GFZ German Research Centre for Geosciences have now ...
JACKSONVILLE, Fla. — Neuroscientists had assumed that a mutation in the progranulin gene, which makes the progranulin protein and supports brain neurons, was sufficient to produce a kind of dementia known as frontotemporal lobar degeneration (FTLD). But now an international team of scientists led by researchers at Mayo Clinic's campus in Florida have found another genetic factor they say appears to protect against the disorder in progranulin mutation carriers.
In an article published in the Dec. 22, 2010, issue of Neurology, the medical journal of the American Academy ...
JUPITER, FL, December 22, 2010 – A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer.
The study is published in the December 24, 2010 edition of the Journal of Molecular Biology.
The study identified the molecular switch, essentially formed by a small ...
AURORA, Colo. (Dec. 22, 2010)—A class of drugs thought to kill cancer cells may in fact block "cross talk" between the cancer cell and normal immune cells, resulting in reduced cancer growth and spread—a discovery that could significantly alter the way cancer drugs are evaluated in the future.
Researchers at the University of Colorado Cancer Center demonstrated the discovery in bladder cancer, the fifth most common cancer in the United States. Bladder cancer will kill about 14,000 Americans this year, most of whom will die as a result of the disease's spread to other ...
University Park, Pa. -- A computer program that automatically analyzes mounds of satellite images and other data could help climate scientists keep track of complex, constantly changing environmental conditions, according to an international team of researchers.
"All of the data and information that is continually collected by satellites and sensors can cause tons of problems for scientists, who simply don't have the time to analyze every pixel of every satellite image," said James Wang, professor of information sciences and technology, Penn State. "Our goal has been ...
WASHINGTON, D.C., December 22, 2010 -- What can scientists learn from watching a group of people sitting around, chatting, playing movies, reading, and happily making new friends? Quite a lot, says University of Melbourne, Australia acoustician Adam Vogel, who carefully observed this sort of group in a fatigue management study he and his colleagues describe this month in The Journal of the Acoustical Society of America.
Their report shows the effects of sustained wakefulness on speech and describes a novel method to acoustically analyze the effects of fatigue on the central ...
